QUEST DIAGNOSTICS INC
StreetZero Signal 63
About QUEST DIAGNOSTICS INC
Quest Diagnostics Incorporated is a provider of medical diagnostic testing and services, including areas such as allergy and asthma, cancer, chronic disease, and digestive health. Founded in 1967 and headquartered in Secaucus, New Jersey, the company operates as a public entity listed on the NYSE under ticker DGX. It serves the United States, Brazil, and Mexico with annual revenue of $11.03 billion.
LATEST FUNDINGRule 144
$3.0M
Announced 2026-11-09
TOTAL RAISED$3.10B
IN THE NEWS
- 🔗 QUEST DIAGNOSTICS INC
- 🔗 Quest Diagnostics Portfolio Investments, Quest Diagnostics Funds, Quest Diagnostics Exits
- 🔗 Quest Diagnostics - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 Quest Diagnostics - Wikipedia
- 🔗 Quest Diagnostics’ Q4HE Initiative Advances Health Equity in Underserved Communities With Strategic Coalition Building and Targeted Funding in 2023
EMPLOYEES48000
FOUNDED1967
HQSecaucus, NJ, United States
Industry
Public Equity (NYSE)
Tags
HealthcareDiagnosticsPublic Company
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Quest Diagnostics is a NYSE-listed public company (DGX) with a market cap of approximately $28.21 billion.
- It reported annual revenue of $11.03 billion and quarterly revenue of $2.82 billion.
- The company has executed multiple large post-IPO debt rounds since 2023 totaling over $3 billion.
- Founded in 1967, Quest Diagnostics provides testing services across the US, Brazil, and Mexico.
Ask StreetZero about QUEST DIAGNOSTICS INC
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account